{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:59:51Z","timestamp":1740124791634,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41371-021-00537-0","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T09:07:14Z","timestamp":1617959234000},"page":"825-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Renal tubular transport protein regulation in primary aldosteronism: can large-scale proteomic analysis offer a new insight?"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-7048","authenticated-orcid":false,"given":"Konstantinos","family":"Stavropoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios","family":"Kassimatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-8044","authenticated-orcid":false,"given":"Michael","family":"Doumas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-4018","authenticated-orcid":false,"given":"Pantelis","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"537_CR1","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:3\u201317.","journal-title":"J Lab Clin Med"},{"key":"537_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/1573402115666190415155512","volume":"16","author":"K Stavropoulos","year":"2020","unstructured":"Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, et al. Primary aldosteronism: novel insights. Curr Hypertens Rev. 2020;16:19\u201323.","journal-title":"Curr Hypertens Rev"},{"key":"537_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"537_CR4","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","volume":"371","author":"S Douma","year":"2008","unstructured":"Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008;371:1921\u20136.","journal-title":"Lancet"},{"key":"537_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6:42\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"537_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","volume":"38","author":"F Monticone","year":"2020","unstructured":"Monticone F, Sconfienze E, D\u2019Ascenzo F, Buffolo F, Satoh F, Sechi LA, et al. Renal damage in primary aldosteronism: a systematic review and meta-analysis. J Hypertens. 2020;38:3\u201312.","journal-title":"J Hypertens"},{"key":"537_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40620-020-00700-9","volume":"33","author":"GM Rossi","year":"2020","unstructured":"Rossi GM, Regolisti G, Peyronel F, Fiaccadori E. Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: implications on pathophysiology and drug discovery. J Nephrol. 2020;33:447\u201366.","journal-title":"J Nephrol"},{"key":"537_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1681\/ASN.2015111221","volume":"28","author":"MJ Wolley","year":"2017","unstructured":"Wolley MJ, Wu AH, Xu SX, Gordon RD, Fenton RA, Stowasser M. In primary aldosteronism, mineralocorticoids influence exosomal sodium-chloride cotransporter abundance. J Am Soc Nephrol. 2017;28:56\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"537_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40620-019-00684-1","volume":"33","author":"GM Rossi","year":"2020","unstructured":"Rossi GM, Regolisti G, Peyronel F, Fiaccadori E. Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: a review of the relevant physiology. J Nephrol. 2020;33:431\u201345.","journal-title":"J Nephrol"},{"key":"537_CR10","doi-asserted-by":"publisher","first-page":"13368","DOI":"10.1073\/pnas.1202671109","volume":"109","author":"M Soleimani","year":"2012","unstructured":"Soleimani M, Barone S, Xu L, Shull GE, Sidiqqui F, Zahedi K, et al. Double knockout of pendrin and Na-Cl cotransporter (NCC) causes severe salt wasting, volume depletion, and renal failure. Proc Natl Acad Sci USA. 2012;109:13368\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"537_CR11","first-page":"1137","volume":"32","author":"F Trepiccione","year":"2017","unstructured":"Trepiccione F, Soukaseum C, Baudrie V, Kumai Y, Teulon J, Villoutreix B, et al. Acute genetic ablation of pendrin lowers blood pressure in mice. Nephrol Dial Transpl. 2017;32:1137\u201345.","journal-title":"Nephrol Dial Transpl"},{"key":"537_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1681\/ASN.2012080787","volume":"24","author":"T Jacques","year":"2013","unstructured":"Jacques T, Picard N, Miller RL, Riemondy KA, Houillier P, Sohet F, et al. Overexpression of pendrin in intercalated cells produces chloride-sensitive hypertension. J Am Soc Nephrol. 2013;24:1104\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"537_CR13","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1681\/ASN.2015121312","volume":"27","author":"O Cil","year":"2016","unstructured":"Cil O, Haggie PM, Phuan PW, Tan JA, Verkman AS. Small-molecule inhibitors of pendrin potentiate the diuretic action of furosemide. J Am Soc Nephrol. 2016;27:3706\u201314.","journal-title":"J Am Soc Nephrol"},{"key":"537_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/cpt.754","volume":"102","author":"CJ Cheng","year":"2017","unstructured":"Cheng CJ, Rodan AR, Huang CL. Emerging targets of diuretic therapy. Clin Pharm Ther. 2017;102:420\u201335.","journal-title":"Clin Pharm Ther"},{"key":"537_CR15","unstructured":"Wu A, Wolley AJ, Wu Q, Gordon RD, Fenton RA, Stowasser M. The Cl\u2212\/HCO3\u2212 exchanger pendrin is downregulated during oral co-administration of exogenous mineralocorticoid and KCl in patients with primary aldosteronism. J Hum Hypertens. (In press)."}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00537-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00537-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00537-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T23:05:22Z","timestamp":1633907122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00537-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1038\/s41371-021-00537-0","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"type":"print","value":"0950-9240"},{"type":"electronic","value":"1476-5527"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"assertion":[{"value":"6 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}